4//SEC Filing
Vanda Pharmaceuticals Inc. 4
Accession 0001209191-16-099404
$VNDACIK 0001347178operating
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 5:30 PM ET
Size
8.2 KB
Accession
0001209191-16-099404
Insider Transaction Report
Form 4
Baroldi Paolo
SVP & Chief Medical Officer
Transactions
- Award
Restricted Stock Unit
2016-02-12+30,000→ 30,000 total→ Common Stock (30,000 underlying) - Award
Employee Stock Option (Right to Buy)
2016-02-12+70,000→ 70,000 totalExercise: $7.94Exp: 2026-02-11→ Common Stock (70,000 underlying)
Footnotes (4)
- [F1]The shares subject to this option shall vest in forty-eight (48) equal monthly installments beginning March 12, 2016, provided Reporting Person remains continuously employed by the Issuer through each monthly vesting date.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive a share of the Issuer's common stock.
- [F3]The RSUs shall vest in four (4) equal annual installments beginning January 1, 2017, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissable Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
- [F4]Not Applicable.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001347178
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 5:30 PM ET
- Size
- 8.2 KB